VIDEO: MGMA explains why the COVID-19 public health emergency extension is critical

Amy Baxter | | Health Exec | Policy & Regulations

The public health emergency was recently extended by the Department of Health and Human Services (HHS) on Oct. 13. The extension ensures healthcare organizations are still afforded the flexibilities granted during the early days of the pandemic and avoids the "telehealth cliff," according to Ernst. 

A PHE lasts for 90 days, but can be renewed and extended by the HHS secretary. The COVID-19 PHE has leveraged emergency waivers, regulations, enforcement discretion and sub-regulatory guidance to offer more flexibilities to providers and improve access to care.

HHS has previously stated it will provide 60 days' notice before ending the PHE to give providers time to adjust. However, extending the PHE while the pandemic is still ongoing is critical, according to Ernst. 

Related Content

Health officials say another COVID-19 wave is on its way
CDC director slams agency's response to COVID-19 pandemic
Monkeypox declared public health emergency
VIDEO: AMA says climate change is a public health emergency
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”